"Almagel" for children: instructions, effect on the child's body. Almagel - official* instructions for use
Additional components: hyaetellose, sorbitol, water, ethanol, propyl parahydroxybenzoate, lemon oil, butyl parahydroxybenzoate, methyl parahydroxybenzoate, sodium saccharinate dihydrate.
Release form
Almagel A is produced in the form of a white suspension with a specific lemon odor. A transparent layer of liquid may form on the surface during long-term storage.
Vigorous shaking restores the homogeneity of the suspension structure. The cardboard box contains a 170 ml bottle, instructions from the manufacturer and a special measuring spoon.
pharmachologic effect
Almagel A reduces activity during the digestion of food, which is achieved by neutralizing free hydrochloric acid in the stomach cavity. Under the influence of the medication, the negative impact of damaging, traumatic factors on the mucous membranes is reduced. The drug has an enveloping effect and an adsorbing effect.
Included in benzocaine has a long-lasting, local analgesic effect, which helps relieve severe pain syndromes in aggressive gastroenterological diseases. For sorbitol characterized by a laxative effect, the component enhances.
The drug is evenly distributed over the entire surface of the stomach, protecting the mucous membranes and preventing the formation of carbon dioxide, which causes.
Pharmacodynamics and pharmacokinetics
The components of the medication are not absorbed through the mucous walls and do not enter the bloodstream. Proper use of the medication does not lead to electrolyte imbalance, resorption in the digestive tract and does not provoke the development alkalosis , violations.
It was noted that even with long-term therapy, the medication does not provoke the formation of stones in the urinary system and does not irritate the urinary tract.
Indications for use Almagel A
The drug is used in gastroenterology, having a beneficial effect on the mucous membranes of the digestive system.
Main indications for use of Almagel A:
- gastritis ( , );
- hernia of the esophagus in the diaphragm;
- duodenitis ;
- epigastric pain due to abuse of coffee, nicotine or alcohol;
- errors in diet;
- reflux esophagitis (content abandonment);
- therapy with NSAIDs and glucocorticosteroids.
Almagel A is prescribed for complex therapy to patients with.
Contraindications
- treatment with sulfonamides;
- diseases of the renal system;
- Age limit: up to one month of age.
Side effects
- stomach cramps;
- vomit ;
- change in taste perception;
- epigastric pain;
- nausea ;
Long-term treatment and simultaneous consumption of food poor in phosphorus in predisposed patients leads to severe phosphorus deficiency in the body, increased calcium resorption, and its excretion by the renal system.
In some cases it is registered osteomalacia . During treatment, it is recommended to eat foods rich in phosphorus. In addition to osteomalacia, patients with chronic diseases of the renal system develop:
- swelling;
- hypermagnesemia.
Almagel, instructions for use (Method and dosage)
Instructions for use Almagel A
The medication is taken orally 30 minutes before meals and before bedtime. Frequency – 3-4 times a day, single dose – 1-3 dosage spoons.
For children 10-15 years old, the drug is prescribed at the rate of ½ adult dose; children under 10 years old – 1/3.
For gastroenterological diseases accompanied by epigastric pain, vomiting and nausea, therapy begins with Almagel A , then switch to simple. The packaging of Almagel A is yellow, and that of ordinary Almagel is green. Vials must be shaken before use to restore the homogeneous structure of the suspension.
Overdose
An increase in the severity of the described adverse reactions is recorded.
Interaction
Medicines whose effectiveness decreases when taken together with Almagel A:
- digitalis glycosides;
- and all tetracyclines;
- iron salts;
- antihistamines;
- beta blockers;
- Phenothiazines;
The last update of the description by the manufacturer was 07/15/2008
Filterable list
Active substance:
ATX
Pharmacological group
Nosological classification (ICD-10)
3D images
Composition and release form
5 ml of oral suspension contains aluminum hydroxide 300 mg (equivalent to 200 mg aluminum oxide), magnesium hydroxide 100 mg and anesthesin 100 mg; in plastic bottles of 170 ml, complete with a dosing spoon, 1 bottle in a cardboard box.
Characteristic
A suspension of white or slightly grayish color with a characteristic sweetish taste and smell of lemon.
pharmachologic effect
pharmachologic effect- enveloping, adsorbent, antacid.Neutralizes hydrochloric acid and reduces the activity of pepsin in gastric juice, protects the gastrointestinal mucosa from damaging effects.
Pharmacodynamics
It is evenly distributed throughout the gastric mucosa, providing long-lasting gastroprotection and local anesthesia. It has a buffer-antacid effect: between doses, the pH of gastric juice is maintained from 4-4.5 to 3.5-3.8. Sorbitol has a choleretic and mild laxative effect. The therapeutic effect appears after 3-5 minutes and lasts 70 minutes.
Pharmacokinetics
Practically not absorbed from the gastrointestinal tract.
Indications of the drug Almagel A
Peptic ulcer of the stomach and duodenum (acute phase), acute or chronic gastritis with normal or increased secretory function (exacerbation phase), reflux esophagitis, diaphragmatic hernia, duodenitis, enteritis, discomfort and pain in the epigastric region caused by poor diet, taking medications drugs (NSAIDs, glucocorticoids), drinking coffee or alcohol, smoking.
Contraindications
Hypersensitivity, severe renal dysfunction, Alzheimer's disease, neonatal period, breastfeeding.
Use during pregnancy and breastfeeding
During pregnancy, use is possible for no longer than 3 days. Breastfeeding should be stopped during treatment.
Side effects
From the gastrointestinal tract: taste disturbance, nausea, vomiting, spasm, pain in the epigastric region, constipation.
From the side of metabolism: hypercalciuria, hypermagnesemia, hypophosphatemia.
Other: drowsiness, osteomalacia, dementia and swelling of the extremities (due to chronic renal failure).
Interaction
Reduces the effectiveness of tetracyclines, H2-histamine receptor blockers, cardiac glycosides, iron salts, ciprofloxacin, phenothiazines, isoniazid, beta-blockers, indomethacin, ketoconazole, etc. (when administered together, an interval between doses of at least 1-2 hours is recommended). Incompatible with sulfonamides.
Directions for use and doses
Orally, 0.5 hours before meals and at night, adults 1-3 dosage spoons, depending on the severity of the case, 3-4 times a day.
For children, strictly as prescribed by the doctor: up to 10 years - 1/3 dose for adults, 10-15 years - 1/2 dose.
The maximum daily dose is 16 dosage spoons, with this dose the duration of treatment is no more than 2 weeks.
The suspension should be shaken before use.
For a disease accompanied by nausea, vomiting and abdominal pain, treatment begins with Almagel A, and after the disappearance of the listed symptoms, they switch to taking Almagel.
Precautionary measures
With long-term use, it is necessary to ensure sufficient intake of phosphorus from food.
Storage conditions for the drug Almagel A
At a temperature not exceeding 25 °C (do not freeze).Keep out of the reach of children.
Shelf life of the drug Almagel A
2 years.Do not use after the expiration date stated on the package.
Synonyms of nosological groups
| Category ICD-10 | Synonyms of diseases according to ICD-10 |
|---|---|
| K21.0 Gastroesophageal reflux with esophagitis | Reflux gastritis |
| Reflux esophagitis | |
| Erosive-ulcerative esophagitis | |
| K25 Stomach ulcer | Helicobacter pylori |
| Pain syndrome with gastric ulcer | |
| Inflammation of the gastric mucosa | |
| Inflammation of the gastrointestinal mucosa | |
| Benign gastric ulcer | |
| Exacerbation of peptic ulcer | |
| Exacerbation of gastric ulcer | |
| Organic gastrointestinal disease | |
| Postoperative gastric ulcer | |
| Ulcer recurrence | |
| Symptomatic stomach ulcers | |
| Helicobacteriosis | |
| Chronic inflammatory disease of the upper gastrointestinal tract associated with Helicobacter pylori | |
| Erosive and ulcerative lesions of the stomach | |
| Erosive lesions of the stomach | |
| Erosion of the gastric mucosa | |
| Peptic ulcer | |
| Stomach ulcer | |
| Gastric ulcer | |
| Ulcerative lesions of the stomach | |
| K26 Duodenal ulcer | Pain syndrome in duodenal ulcer |
| Pain syndrome in gastric and duodenal ulcers | |
| Disease of the stomach and duodenum associated with Helicobacter pylori | |
| Exacerbation of peptic ulcer | |
| Exacerbation of duodenal ulcer | |
| Peptic ulcer of the stomach and duodenum | |
| Recurrence of duodenal ulcer | |
| Symptomatic ulcers of the stomach and duodenum | |
| Helicobacteriosis | |
| Helicobacter pylori eradication | |
| Erosive and ulcerative lesions of the duodenum | |
| Erosive and ulcerative lesions of the duodenum associated with Helicobacter pylori | |
| Erosive lesions of the duodenum | |
| Duodenal ulcer | |
| Ulcerative lesions of the duodenum | |
| K29 Gastritis and duodenitis | Duodenitis |
| Exacerbation of gastroduodenitis against the background of peptic ulcer | |
| K29.1 Other acute gastritis | Acute gastritis (erosive) |
| Erosive gastritis | |
| Acute gastritis | |
| K29.5 Chronic gastritis, unspecified | Pain in chronic gastritis with high acidity |
| Chronic gastritis | |
| Gastroenteritis | |
| Gastroenteritis | |
| Metaplasia of the gastric mucosa | |
| Acute gastroenteritis | |
| Chronic gastritis | |
| Chronic diseases of the digestive system | |
| Chronic autoimmune gastritis | |
| Chronic gastritis | |
| Chronic gastritis in the acute stage | |
| Chronic gastritis with normal secretory function | |
| Chronic gastritis with normal gastric secretory function | |
| Chronic gastritis with normal secretion | |
| Chronic gastritis with increased and normal secretory function of the stomach | |
| Chronic gastritis with increased secretory function | |
| Chronic gastritis with increased secretory function of the stomach | |
| Chronic gastritis with increased secretion | |
| Chronic gastritis with decreased secretory function | |
| Chronic gastritis with secretory insufficiency | |
| K52.9 Non-infectious gastroenteritis and colitis, unspecified | Hemocolitis |
| Digestive tract infections | |
| Infectious disease of the gastrointestinal tract | |
| Antibiotic-associated colitis | |
| Collagenous colitis | |
| Chronic diarrhea | |
| Old Gut Syndrome | |
| Mucous colitis | |
| Chronic colitis | |
| Chronic enteritis | |
| R52.2 Other persistent pain | Pain syndrome of non-rheumatic origin |
| Pain syndrome with vertebrogenic lesions | |
| Pain syndrome with neuralgia | |
| Pain syndrome from burns | |
| Pain syndrome is mild or moderate | |
| Neuropathic pain | |
| Neuropathic pain | |
| Perioperative pain | |
| Moderate to severe pain | |
| Moderate or mild pain syndrome | |
| Moderate to severe pain syndrome | |
| Ear pain due to otitis media | |
| Z72.4 Inappropriate diet and unhealthy eating habits | Dyspepsia caused by unusual foods or overeating |
| Long-term diet therapy | |
| Long-term or low-calorie diets | |
| Gastrointestinal disorders caused by poor diet | |
| Inadequate nutrition | |
| Irregular eating | |
| Unbalanced diets | |
| Binge eating | |
| Food poisoning | |
| Errors in diet | |
| Dieting | |
| Following a strict diet | |
| Special diets |
Almagel A (aluminum hydroxide + magnesium hydroxide + benzocaine) is an antacid drug, “enhanced” by the addition of an anesthetic. The drug neutralizes free hydrochloric acid in the stomach, which reduces the digestive ability of gastric juice. The drug does not cause the so-called “acid rebound” - the development of secondary gastric hypersecretion. It has a local anesthetic, enveloping and adsorbing effect, neutralizes the influence of aggressive factors on the mucous membrane of the gastrointestinal tract. The drug begins to act within 3-5 minutes from the moment of administration and provides a lasting and pronounced therapeutic effect for 70 minutes. During this entire time, Almagel A ensures stable neutralization of constantly produced gastric juice and reduces the concentration of hydrochloric acid in it to the required limits. Aluminum hydroxide (alhedrate) inhibits the secretion of pepsin, neutralizes hydrochloric acid with the formation of aluminum chloride, which, in turn, entering the intestines and swallowing the local alkaline “spirit of freedom”, turns into an alkaline salt. Magnesium hydroxide also neutralizes hydrochloric acid, forming magnesium chloride. The antagonistic nature of magnesium hydroxide in relation to the tendency of aluminum hydroxide to cause constipation ensures the uninterrupted functioning of the physiological “conveyor” of the digestive tract. The third in line, but not least important, component of Almagel A - benzocaine - has a long-lasting and pronounced local anesthetic effect. Sorbitol included in the drug as an excipient facilitates bile excretion and exhibits a mild laxative effect, harmoniously complementing the action of magnesium hydroxide. Almagel A smoothly but confidently shifts the pH to the “alkaline” side, “anchoring” it within physiological limits from 3.5 to 4.5. The drug forms a protective shell, ensuring uniform distribution of active substances on the gastric mucosa, and has a long-lasting local effect without the formation of carbon dioxide in the stomach, which, in turn, causes flatulence, discomfort in the epigastric region and secondary hypersecretion of hydrochloric acid.
Almagel neo is practically non-toxic: it does not have teratogenic or mutagenic effects. In isolated cases, increased tendon reflexes were observed in newborns whose mothers took the drug for a long time. In addition, in newborns there is a risk of a pathological increase in the amount of magnesium in the blood plasma, especially in a state of dehydration, and therefore long-term use of the drug for pregnant women and newborns is not recommended.
Almagel A is practically not absorbed from the gastrointestinal tract. The drug does not disturb the water-salt balance and does not create any prerequisites for the occurrence of alkalosis and other metabolic disorders. Almagel A does not have an irritating effect on the urogenital tract and does not contribute to the formation of stones even with a long course of medication. Available in the form of a suspension for oral administration. A measuring spoon is included in the package with the drug to ensure dosing accuracy. A single dose for adults is 1-3 scoops (their quantity is determined by the severity of the clinical case). Frequency of administration: 3-4 times a day, 30 minutes before meals and before bedtime. The maximum daily dose is 16 spoons. In children, the drug is used exclusively as prescribed by a doctor and under medical supervision: children under 10 years of age take a third of the “adult” dose, children from 10 to 15 years of age take half. For diseases that are clinically manifested by nausea, vomiting and abdominal pain, pharmacotherapy begins with Almagel A, then the patient is transferred to Almagel. The bottle of the drug must be shaken before use. It is not recommended to take any other medications 1-2 hours before taking Almagel A and the same time after it.
Pharmacology
The instructions were approved by the Pharmacological Committee of the Russian Ministry of Health on March 2, 2001.
Almagel A neutralizes free hydrochloric acid in the stomach, which leads to a decrease in the digestive activity of gastric juice. Does not cause secondary hypersecretion of gastric juice. It has a local anesthetic, adsorbing and enveloping effect, reduces the effect of damaging factors on the mucous membrane.
The therapeutic effect after taking the drug occurs within 3-5 minutes and lasts an average of 70 minutes.
Almagel A provides long-term local neutralization of continuously secreted gastric juice and reduces the content of hydrochloric acid in it to optimal limits for treatment. Aluminum hydroxide suppresses the secretion of pepsin, neutralizes hydrochloric acid, forming aluminum chloride, which in the alkaline environment of the intestine turns into alkaline aluminum salts. Magnesium hydroxide also neutralizes hydrochloric acid, turning into magnesium chloride. This counteracts the constipating effects of aluminum hydroxide. Magnesium hydroxide and magnesium chloride are resorbed to an insignificant extent and have virtually no effect on the concentration of magnesium ions in the blood.
Benzocaine has an effective and long-lasting local analgesic effect in severe pain.
Sorbitol, which is part of the drug, promotes increased secretion of bile and exhibits a mild laxative effect, complementing the effect of magnesium hydroxide.
Almagel A does not sharply increase the pH of the stomach contents; it buffers its value from 4.0–4.5 to 3.5–3.8 (physiological value) in the period between doses. The drug forms a protective layer, ensuring uniform distribution of active substances on the gastric mucosa and has a long-lasting local effect without the subsequent formation of carbon dioxide in the stomach, which, in turn, causes flatulence, a feeling of heaviness in the epigastric region and a secondary increase in the secretion of hydrochloric acid.
According to the Hodge and Sterner classification, the drug, when administered orally, is classified as a mildly toxic agent and does not have embryotoxic, teratogenic or mutagenic effects. In some cases, increased tendon reflexes were noted in newborns whose mothers took the drug for a long time. In addition, in newborns there is a risk of developing hypermagnesemia, especially in a state of dehydration, therefore long-term use of the drug for pregnant women and newborns is not recommended.
Pharmacokinetics
Almagel A is a non-absorbable drug. If the correct dosage regimen and duration of treatment are observed, it is practically not resorbed in the gastrointestinal tract and has a long-lasting, uniform effect without disturbing the electrolyte balance and without creating the risk of alkalosis or other metabolic disorders. It does not irritate the urinary system and, with long-term use, does not cause alkalosis and the formation of stones in the urinary tract.Release form
Suspension for oral administration is white or almost white in color, with a characteristic odor of lemon; During storage, a layer of transparent liquid may form on the surface; vigorously shaking the bottle will restore the homogeneity of the suspension.
Excipients: sorbitol - 801.15 mg, hyaetellose - 15.26 mg, methyl parahydroxybenzoate - 10.9 mg, propyl parahydroxybenzoate - 1.363 mg, butyl parahydroxybenzoate - 1.363 mg, sodium saccharinate dihydrate - 0.818 mg, lemon oil - 1.635 mg, ethanol 96% - 98. 1 mg, purified water - up to 5 ml.
170 ml - bottles (1) complete with a dosing spoon - cardboard packs.
Dosage
Inside. As prescribed by the doctor, 1-3 dosage (teaspoons) depending on the severity of the case, 3-4 times a day half an hour before meals and in the evening before bed.
For diseases accompanied by nausea, vomiting and abdominal pain, treatment begins with Almagel A, and after the disappearance of the listed symptoms, they switch to taking Almagel.
The bottle should be shaken before use.
Interaction
With simultaneous use, Almagel A can reduce the therapeutic effect of tetracycline antibiotics, histamine H2 receptor blockers, digitalis glycosides, iron salts, ciprofloxacin, phenothiazines, isoniazid, beta-blockers, indomethacin and ketokenozol, etc.
Side effects
In some cases, when taking the drug, changes in taste sensations, nausea, vomiting, stomach cramps, pain in the epigastric region and constipation may occur, which disappear after reducing the dose. May cause drowsiness when used in high doses.
Long-term treatment with high doses of the drug and phosphorus-poor food can lead in predisposed patients to the development of phosphorus deficiency in the body, increased resorption and excretion of calcium in the urine and the occurrence of osteomalacia. Therefore, when taking the drug for a long time, you should ensure a sufficient intake of phosphorus from food.
In patients with chronic renal failure, in addition to osteomalacia, swelling of the extremities, dementia and hypermagnesemia may be observed.
Indications
- peptic ulcer of the stomach and duodenum in the acute phase;
- acute gastritis and chronic gastritis with increased and normal secretory function in the acute phase;
- duodenitis;
- enteritis;
- hiatal hernia;
- reflux esophagitis;
- functional intestinal disorders, colitis;
- discomfort and pain in the epigastrium due to errors in diet, after drinking coffee, nicotine, alcohol;
- prophylactically in the treatment of GCS and NSAIDs.
As part of a complex of therapeutic measures, Almagel A is prescribed to patients with diabetes.
Contraindications
- hypersensitivity to the components of the drug;
- severe renal dysfunction;
- Alzheimer's disease;
- early childhood (up to 1 month).
Do not prescribe simultaneously with sulfonamides due to the presence of benzocaine in the drug.
Features of application
Use during pregnancy and breastfeeding
Avoid administration to nursing mothers.
Use for renal impairment
Contraindicated: severe renal impairment.Use in children
Contraindicated: early childhood (up to 1 month).
In children, the drug is used strictly as prescribed by a doctor: children under 10 years of age are prescribed 1/3 of the dose for adults, and children from 10 to 15 years of age are prescribed 1/2 of the dose for adults.
special instructions
The interval between taking Almagel A and other medications should be 1-2 hours.
When taking the drug for a long time, you should ensure a sufficient intake of phosphorus from food.
Additional components: lemon oil, saccharinate dihydrate, methyl parahydroxybenzoate, hyaetellose, sorbitol, water, butyl parahydroxybenzoate, propyl parahydroxybenzoate, sodium saccharinate dihydrate.
Release form
White suspension intended for oral administration. It has a specific lemon smell. During long-term storage, a transparent layer of liquid forms on the surface. Homogeneity is restored by vigorous shaking of the solution.
Available in bottles of 170 and 200 ml. The cardboard box contains a dosing spoon, a bottle and instructions from the manufacturer. The drug is not available in sachets.
pharmachologic effect
The mechanism of action of the drug is aimed at neutralizing free of hydrochloric acid in the stomach, which is achieved by reducing digestive ability.
The drug does not provoke the development of secondary hypersecretion. The medication has an enveloping effect and an adsorbing effect, protecting the walls of the stomach from the aggressive effects of traumatic factors.
Thanks to Almagel, the pH of gastric juice is reduced to optimal levels. The active component Al hydroxide is capable of inhibiting the activity pepsin , neutralize HCl by forming aluminum chloride, which in the intestinal lumen under the influence of an alkaline environment is converted into alkaline aluminum salts.
Mg hydroxide enhances the neutralizing effect against hydrochloric acid, converting to magnesium chloride. This component helps prevent the development of diarrhea, which is caused by aluminum hydroxide. enhances bile excretion and can cause laxative effect .
The drug forms a protective film on the walls of the stomach, preventing the formation of carbon dioxide, which causes a feeling of heaviness in the epigastrium, increased secondary hypersecretion. The medication does not have mutagenic, embryotoxic or teratogenic effects.
Pharmacodynamics and pharmacokinetics
The active components are not able to be absorbed into the systemic circulation, because form a protective film. Compliance with the dosage regimen and following recommendations for the duration of therapy allows you to avoid effects on electrolyte balance, the development of alkalosis and other manifestations of disorders.
Long-term treatment does not lead to the formation of stones in the urinary system and does not irritate the mucous membranes of the urinary tract. The therapeutic effect can be observed after 5 minutes. The duration of action of the medication is up to 70 minutes (depending on food intake and individual characteristics).
Indications for use of Almagel
What is the drug for?
Most often, the medication is prescribed in gastroenterology to patients with diseases of the digestive system. When active components contribute to the restoration of the stomach wall, protecting against the aggressive effects of adverse factors (high acidity, spicy foods, etc.).
Main indications for use of Almagel
- duodenitis (pathology of the duodenum of an inflammatory nature);
- functional intestinal disorders;
- reflux esophagitis (reflux);
- hiatal hernia in the diaphragm;
- errors in diet, abuse of nicotine, coffee, alcohol;
When in the inactive phase, treatment with glucocorticosteroids and drugs from the NSAID group can provoke an exacerbation of the disease. Prescribing Almagel for prevention helps to avoid relapse.
Contraindications
- diseases of the liver system;
- individual hypersensitivity.
Age contraindications – before reaching the age of one month.
Side effects
Metabolism:
- hypermagnesemia;
- hypercalciuria;
- hypophosphatemia.
Digestive tract:
- constipation;
- epigastric pain;
- taste disturbances;
- spasms;
- vomit;
- nausea.
Rarely recorded:
- limbs (as a result of pathology of the renal system);
- osteomalacia ;
- increased.
Almagel, instructions for use (Method and dosage)
According to the instructions for use of Almagel, the medication is taken half an hour before meals 3-4 times a day, 1-3 tablespoons. Additionally, it is recommended to take the medication before bedtime. For ulcerative pathology of the digestive tract, the suspension is taken between main meals. Once the result is achieved, it is recommended to continue maintenance therapy for 2-3 months, taking 1 spoon 3-4 times a day.
How to take the drug for children 10-15 years old - at the rate of ½ dose for adults, for children under 10 years old - 1/3 dose.
You can take no more than 16 spoons per day (the duration of treatment with this dosage is no more than 14 days). Vials with suspension must be shaken.
Pills ( Almagel T ) are prescribed up to 6 times a day, 1-2 pieces. Negative symptoms stop after 30-60 minutes when taking the medication on an empty stomach. The duration of treatment is 10-15 days.
Overdose
It manifests itself as complete or partial inhibition of the motility of the digestive tract. In such cases, it is recommended to prescribe laxative medications.
Interaction
Drugs that lose their effectiveness when treated with Almagel:
- digitalis glycosides;
- tetracycline;
- iron salts;
- histamine receptor blockers (H2);
- phenothiazines;
Terms of sale (recipe in Latin)
Dispensing without a prescription is allowed.
Rp.: Almageli 170.0 (or 200.0 depending on the volume of the bottle)
D.t. d. N 2 in lagenis
S. 1-3 spoons 3-4 times a day.
Storage conditions
Do not allow the suspension to freeze (affects efficiency). The optimal temperature for storing bottles is 5-15 degrees.
Antacid drug in combination with local anesthetic
Active ingredients
Benzocaine
- magnesium hydroxide paste (magnesium hydroxide)
- algeldrate (aluminum hydroxide gel) (algeldrate)
Release form, composition and packaging
◊ Oral suspension white or almost white in color, with a characteristic lemon smell; During storage, a layer of transparent liquid may form on the surface; vigorously shaking the bottle will restore the homogeneity of the suspension.
Excipients: sorbitol - 801.15 mg, hyaetellose - 15.26 mg, methyl parahydroxybenzoate - 10.9 mg, propyl parahydroxybenzoate - 1.363 mg, butyl parahydroxybenzoate - 1.363 mg, sodium saccharinate dihydrate - 0.818 mg, lemon oil - 1.635 mg, ethanol 96% - 98. 1 mg, purified water - up to 5 ml.
170 ml - bottles (1) complete with a dosing spoon - cardboard packs.
pharmachologic effect
The instructions were approved by the Pharmacological Committee of the Russian Ministry of Health on March 2, 2001.
- early childhood (up to 1 month).
Do not prescribe simultaneously with sulfonamides due to the presence of benzocaine in the drug.
Dosage
Inside. As prescribed by the doctor, 1-3 dosage (teaspoons) depending on the severity of the case, 3-4 times a day half an hour before meals and in the evening before bed.
U children The drug is used strictly as prescribed by the doctor: children under 10 years old 1/3 of the dose is prescribed for adults, and children from 10 to 15 years old- 1/2 dose for adults.
At diseases accompanied by nausea, vomiting and, treatment begins with Almagel A, and after the disappearance of the listed symptoms, they switch to taking Almagel.
The bottle should be shaken before use.
Side effects
In some cases, when taking the drug, changes in taste sensations, nausea, vomiting, stomach cramps, pain in the epigastric region and constipation may occur, which disappear after reducing the dose. May cause drowsiness when used in high doses.
Long-term treatment with high doses of the drug and phosphorus-poor food can lead in predisposed patients to the development of phosphorus deficiency in the body, increased resorption and excretion of calcium in the urine and the occurrence of osteomalacia. Therefore, when taking the drug for a long time, you should ensure a sufficient intake of phosphorus from food.
In patients with chronic, in addition to osteomalacia, swelling of the extremities, dementia and hypermagnesemia may be observed.
Drug interactions
With simultaneous use, Almagel A can reduce the therapeutic effect of tetracycline antibiotics, histamine H2 receptor blockers, digitalis glycosides, iron salts, ciprofloxacin, phenothiazines,
